Results 31 to 40 of about 7,372 (214)

Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer

open access: yesJournal of Experimental & Clinical Cancer Research, 2023
Background The Hippo pathway is crucial in organ size control and tumorigenesis. Dysregulation of the Hippo/YAP axis is commonly observed in gastric cancer, while effective therapeutic targets for the Hippo/YAP axis are lacking.
Tianshi Wang   +16 more
doaj   +1 more source

CXCR7 in tumorigenesis and progression

open access: yesChinese Journal of Cancer, 2010
Chemokines, a family of small cytokines, were initially characterized as proinflammatory chemoattractant cytokines that regulated cell trafficking and adhesion. Today, attention focuses on chemokines because evidence shows that they play a critical role in tumor initiation, promotion, and progression.
Kai-Lin, Hou   +3 more
openaire   +2 more sources

Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma. [PDF]

open access: yesPLoS ONE, 2012
Neuroblastoma (NB) is a typical childhood and heterogeneous neoplasm for which efficient targeted therapies for high-risk tumors are not yet identified.
Julie Liberman   +8 more
doaj   +1 more source

CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease. [PDF]

open access: yesPLoS ONE, 2016
Coronary artery disease (CAD) is characterized by insufficient vasculogenic response to ischemia, which is typically accompanied by dysfunction of endothelial outgrowth cells (EOCs).
Zheng Cao   +7 more
doaj   +1 more source

CXCR7-mediated progression of osteosarcoma in the lungs [PDF]

open access: yesBritish Journal of Cancer, 2013
Osteosarcoma (OS) is the most frequent primary malignant bone tumour in children and adolescents with a high propensity for lung metastasis. Chemokines and chemokine receptors have been described to have an important role in many malignancies including OS.
Goguet-Surmenian, E   +10 more
openaire   +2 more sources

CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes [PDF]

open access: yesCurrent Drug Targets, 2016
Many studies have suggested that CXCR3, CXCR5, CXCR6 and CXCR7 chemokine receptors are determinant in type 1 diabetes (T1D), expecially in autoimmunity and β-cell destruction. In particular circulating CXCL10 level (the ligand of CXCR3) is high in T1D patients, and this suggests that CXCL10 may be a candidate for a predictive marker of T1D.
Fallahi, P.   +5 more
openaire   +3 more sources

Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth

open access: yesThe Journal of Clinical Investigation, 2023
CXCR7 is an atypical chemokine receptor that recruits β-arrestin (ARRB2) and internalizes into clathrin-coated intracellular vesicles where the complex acts as a scaffold for cytoplasmic kinase assembly and signal transduction. Here, we report that CXCR7
Galina Gritsina   +14 more
doaj   +1 more source

Pathogenic role of CXCR7 in rheumatoid arthritis [PDF]

open access: yesArthritis & Rheumatism, 2010
AbstractObjectiveThe interaction between CXCL12 and its receptor, CXCR4, in the synovium of patients with rheumatoid arthritis (RA) is important for local inflammatory cell recruitment, angiogenesis, and cytokine production. CXCR7 was recently identified as an alternative receptor for CXCL12.
Kaori, Watanabe   +9 more
openaire   +2 more sources

Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer

open access: yesCancer Medicine, 2019
Background Studies have shown that CXCR7 is expressed in many tumors. The aim of the present study was to investigate the function of CXCR7 in colon cancer.
Xiang Li   +4 more
doaj   +1 more source

Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells

open access: yesJournal of Experimental & Clinical Cancer Research, 2010
Background In spite of recent advances in diagnostic and therapeutic measures, the prognosis of hepatocellular carcinoma (HCC) patients remains poor.
Li Fan   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy